REUTERS: Procter & Gamble's Intrinsa testosterone patches appear to not do much to boost a woman's sex drive after menopause and their long-term safety is unclear, a review found on Tuesday.
Intrinsa is licensed for use in Europe but not in the United States where, in 2004, regulators voted against approving the patches that deliver the male hormone, citing lack of evidence for their long-term safety.
"The published evidence so far is based on highly selected women and only shows small improvements in sexual parameters and large placebo responses," Ike Iheanacho, editor of the Drug and Therapeutics Bulletin, which published the review of published studies.
"Also the long term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction."
Procter & Gamble could not be immediately reached for comment.
Read more hot stories Moms Are Talking About.